BENGAY

This brand name is authorized in Israel, Poland, Turkey

Active ingredients

The drug BENGAY contains a combination of these active pharmaceutical ingredients (APIs):

1 Methyl salicylate
UNII LAV5U5022Y - METHYL SALICYLATE

Methyl salicylate has the action of salicylates, causing dilation of the skin vessels. Methyl salicylate is used to prevent bed sores and for hardening the skin of the feet.

Read about Methyl salicylate
2 Menthol
UNII L7T10EIP3A - MENTHOL, UNSPECIFIED FORM
Read about Menthol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M02AC Preparations with salicylic acid derivatives M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain
Discover more medicines within M02AC

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 3053, 3119, 3990
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100009274
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8683873438013

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.